LIST OF VACCINE REGISTERED IN BANGLADESH
Sl. |
Brand Name |
Generic Name & Strength |
Dosages |
DAR No. |
Name of Manufacturer |
Validity |
Local Agent |
1. |
Verorab |
Rabies Virus |
Vaccine |
102-2402-91 |
Sanofi Pasteur S A ,France |
05.05.2024 |
Sanofi Bangladesh Limited., Dhaka |
2. |
Rabipur® |
Rabies Virus 2.5 IU |
Injectable Vaccine |
108-2618-94 |
Chiron Behring Vaccine Pvt. Ltd., |
06.11.2019 |
Renata Ltd, Dhaka |
3. |
Human Antitetanus Immune Globulin Grifols 250 IU Injection |
Human Antitetanus Immune Globulin 250 IU |
Injectable Vaccine |
166-2664-95 |
Instituto Grifols S.A., Spain |
08.05.2010 |
Shuvro Ltd, Dhaka |
4. |
Engerix-B |
Hepatitis B Vaccine |
Vaccine |
62-2499-94 |
Glaxo Smith Kline Bioglan SA, Belgium |
12.06.2018 |
GlaxoSmith Kline Bangladesh Ltd., Dhaka |
5. |
Hepavax Gene |
Hepatitis B Vaccine |
Vaccine |
221-2830-96 |
Berna Biotech, Korea |
13.03.2011 |
Healthcare Marketing Ltd Dhaka |
6. |
Hepavax Gene |
Hepatitis B Vaccine |
Vaccine |
221-2832-96 |
Berna Biotech, Korea |
13.03.2011 |
Healthcare Marketing Ltd Dhaka |
7. |
Maningococcal Polysaccharide Vaccine A+C |
Maningococcal Polysaccharide Vaccine A+C |
Vaccine |
102-2841-96 |
Pasteur Merieux Serums and Vaccines, France |
11.05.2016 |
Sanofi Bangladesh Limited., Dhaka |
8. |
Trimovax Injection |
Vaccinum Morbillorum Vivum, measles, mumps, rubella |
Vaccine |
102-2992-97 |
Sanofi Pasteur SA, France |
26.04.2017 |
Sanofi Bangladesh Limited., Dhaka |
9. |
Varilrix Vaccine |
Live Attenuated Varicella Virus Vaccine OKA Strain |
Vaccine |
229-3156-97 |
Glaxo Smith Kline Biologicals S.A., Belgium |
15.10.2017 |
GlaxoSmith Kline Bangladesh Ltd., Dhaka |
10. |
Priorix Vaccine |
Live Attenuated mumps, Rubella, Measles Vaccine |
Injectable vaccine |
229-3270-98 |
Glaxo Smith Kline Biologicals S.A, Belgium |
17.05.2018 |
GlaxoSmith Kline Bangladesh Ltd., Dhaka |
11. |
Act-HIB |
Haemophilus Influenzae Type B Polysaccjarode 10 ug/dose |
Injectable Vaccine |
107-3173-97 |
Sanofi Pasteur S A, France |
28.10.2017 |
Sanofi Bangladesh Limited., Dhaka |
12. |
Typhim VI |
Purified Vi capsular polysaccharide of salmonella Typhi (Ty 2 strain) 0.025 mg/dose |
Injectable Vaccine |
102-3177-97 |
Sanofi Pasteur S A, France |
05.05.2024 |
Sanofi Bangladesh Limited., Dhaka |
13. |
Hiberix Vaccine |
Haemophilus Infulenzae Type B Vaccine |
Vaccine |
229-3350-98 |
Glaxo Smith Kline Biological S.A., Belgium |
01.09.2018 |
GlaxoSmith Kline Bangladesh Ltd., Dhaka |
14. |
Typherix |
Polysaccharide 25ug/0.5ml P.F.S |
Injectable Vaccine |
229-3551-00 |
Glaxo Smithkline Biologicals S.A., Belgium |
02.04.2020 |
GlaxoSmith Kline Bangladesh Ltd., Dhaka |
15. |
Havrix 1440 |
HAV Antigen (Hepatits A Vaccine) |
Injectable Vaccine |
229-3622-01 |
Glaxo Smith Kline Biologicals S.A., Belgium |
15.04.2021 |
GlaxoSmith Kline Bangladesh Ltd., Dhaka |
16. |
Havrix 720 |
HAV Antigen (Hepatits A Vaccine) |
Injectable Vaccine |
229-3623-01 |
Glaxo Smith Kline Biologicals S.A., Belgium |
15.04.2021 |
GlaxoSmith Kline Bangladesh Ltd., Dhaka |
17. |
Inj. Tetabulin (Tetanus Immunoglobulin Human 250IU) |
Tetanus Antitoxin 250IU
|
Injectable Vaccine |
191-3672-01 |
Baxter AG, Austria |
09.12.2011 |
Swadesh, Dhaka |
18. |
Tritanrix HB |
Diphtheria Toxoid 30IU Tetanus Toxoid 60 IU Inactivated Bordetella Pertussis 4 IU r-DNA HBs AG 10mcg |
Injectabe Vaccine |
105-3681-01 |
Glaxo Smithkline Biologicals, Belgium |
28.12.2016 |
GlaxoSmith Kline Bangladesh Ltd., Dhaka |
19. |
Avaxim, Inactivated Hepatitis A Vaccine |
Inactivated Hepatitis A Virus |
Injectable Vaccine |
102-3796-2004 |
Sanofi Pasteur S.A., France |
16.01.2019 |
Sanofi Bangladesh Limited., Dhaka |
20. |
Avaxim 80 IU Pediatric |
Inactivated Hepatitis A Virus Ph. Eur. 80 antigen units |
Injectable Vaccine |
102-3931-2004 |
Aventis Pasteur S.A., France |
19.06.2019 |
Sanofi Bangladesh Limited., Dhaka |
21. |
Mencevax ACWY Vaccine |
Meningococcal polysaccharide Serogroup A Ph. Eur 50 mcg Meningococcal polysaccharide Serogroup C Ph. Eur 50 mcg Meningococcal polysaccharide Serogroup W135 Ph Eur 50 mcg Meningococcal polysaccharide Serogroup y Ph Eur 50 mcg |
Injectable Vaccine |
105-3956-2004 |
Glaxo SmithKline Biological S.A., Belgium |
24.10.2019 |
GlaxoSmith Kline Bangladesh Ltd., Dhaka |
22. |
Imovax Polio Injection |
Inactivated Poliovirus Type-1 Ph. Eur 40 antigen D unit Inactivated Poliovirus Type-2 Ph. Eur 8 antigen D Unit Inactivated Poliovirus Type-3 Ph. Eur 32 antigen D unit |
Injectable Vaccine |
102-3978-2005 |
Sanofi Aventis Pasteur SA, France |
24.01.2020 |
Sanofi Bangladesh Limited., Dhaka |
23. |
Pentaxim |
Diptheria Toxoid 30 IU Tetanus Toxoid 40 IU Bordetella Pertusis Antigens Toxoid 25 mcg Filamentous Haemagglutinin 25 mcg Inactivated Type 1 Poliomyelitis Virus 40 DU Inactivated Type 2 Poliomylities Virus 8 DU Inactivated Type 3 Poliomyelitis Virus 32 DU Haemophilus Influenzae type B Poliomyelitis virus 10 mcg/ Prefilled syringe |
Injectable Vaccine |
102-4152-2006 |
Sanofi Pasteur, France |
04.02.2021 |
Sanofi Bangladesh Limited., |
24. |
Vaxem HIB 0.5 |
Haemophilus Influenza Type B Vaccine Ph. Eur 10 mcg/5 ml |
Injectable Vaccine |
125-4182-2006 |
Novartis Vaccines and Diagnostics, Italy |
01.04.2011 |
Novartis Bangladesh Ltd., Dhaka |
25. |
Fluarix Vaccine |
A/New Caledonia/20/90 (HINI) Like Strain Ph. Eur 15 mcg A/California/7/2004 (H3N2) like strain Ph. Eur. 15 mcg B/Shanghai/361/2002-like strain Ph. Eur. 15 mcg/dose |
Injectable Vaccine
|
105-4201-2006 |
GlaxoSmithKline Biologicals, Germany
|
28.12.2021 |
GlaxoSmith Kline Bangladesh Ltd., Dhaka |
26. |
Rotarix Vaccine |
Human Rota Virus, live attenuated Rix4414 Strain INN Not less than 106.0 CCID50 |
Injectable Vaccine
|
105-4202-2006 |
GlaxoSmithKline Biologicals SA, Belgium
|
28.12.2021 |
GlaxoSmith Kline Bangladesh Ltd., Dhaka |
27. |
Infanrix hexa |
Diptheria Toxoid (D) min 30IU+Tetanus Toxid (T) min 40IU+ Pertusis Toxoid (PT) 25mcg+Filamentous hemagglutinin (FHA) 25mcg+ Pertactin (69kDa outer memberanc Protein 8mcg + r-DNA Hepatitis B surface antigen (HBsAg) 10mcg+ Inactivated Plolio Virus (IPV) Type 1 40DU+ Inactivated Plolio Virus (IPV) Type 2 8DU + Inactivated Plolio Virus (IPV) Type 3 32DU/0.5ml |
Injectable vaccine |
105-4256-2008 |
GlaxoSmithkline Biologicals S.A, Belgium |
08.09.2018 |
GlaxoSmith Kline Bangladesh Ltd., Dhaka |
28. |
Cervarix |
Human Papillomavirus type 16 L1 Protein1 20mcg +Human Papillomavirus type 18 L1 Protein1 20mcg /0.5ml |
Injectable vaccine |
105-4257-2008 |
GlaxoSmithkline Biologicals S.A, Belgium |
08.09.2018 |
GlaxoSmith Kline Bangladesh Ltd., Dhaka |
29. |
Favirab |
F(ab’)2 Fragment of equine antirabes immune globulin/ml 200-400 IU |
Vaccine |
102-4262-2008 |
Aventis Pasteur, France |
01.11.2018 |
Sanofi Bangladesh Limited., Dhaka |
30. |
Okavax |
An attenuated live Varicella-zoster Virus 1400 PFU+ Sodium Chloride 1.6mg+Potassium Chloride 0.04mg+Monobasic Potassium Phosphate 0.4mg+ Dibasic Sodium Phosphate hydrate 4.395mg+Sucrose 35mg+Monosodium L-glutamate monohydrate 0.5mg+Kanamycin Sulfate 10mcg (potency)+Erythromycin lactobionate 3mcg (potency) /0.7ml |
Injectable Vaccine |
102-4414-2009 |
The Research Foundation for Microbial Disease of Osaka University, Japan |
21.06.2014 |
Sanofi Bangladesh Limited., Dhaka |
31. |
TETRAct-HIB |
Haemophilus Influenza type b polysaccharide conjugated to tetanus Protein 10mcg+Purified diphtheria toxoid 30IU+Purified tetanus toxoid 60IU+Bordetella pertussis 4IU/0.5ml |
Injectable Vaccine |
102-4415-2009 |
Sanofi Pasteur SA, France |
21.06.2014 |
Sanofi Bangladesh Limited., Dhaka |
32. |
Rotarix |
Human Rota Virus, Live attenuated, RIX 4414 Strain Not less than 106 CCID50/ 1.5ml |
Oral Vaccine |
105-4470-2010 |
GlaxoSmithKline Biologicals S.A, Belgium |
27.01.2021 |
Sanofi Bangladesh Limited., Dhaka |
33. |
Pneumo-23 |
Purified capsular polysaccharides of Streptococcus pneumoniae 1,2,3,4,5.6B, 7F,8,9N,9V,10A, 11A,12F,14, 15B,17F, 18C, 19A,19F,20,22F,23F, 33F for Each of the 23 serotypes 25mcg/ 0.5ml in P.F.S |
Injectable Vaccine |
102-4473-10 |
Sanofi Pasteur SA , France |
15.02.2020 |
Sanofi Bangladesh Limited., Dhaka |
34. |
Vaxigrip |
A.Brisbane/59/2007(H1N1) 15mcgHA+ A/Brisbane/10/2007(H3N2) 15mcgHA+ B/Florida/4/2006 15mcgHA/0.5ml in P.F.S |
Injectable Vaccine |
102-4474-10 |
Sanofi Pasteur SA, France |
15.02.2025 |
Sanofi Bangladesh Limited., Dhaka |
35. |
Tetraxim |
Diphtheria Toxoid ≥ 30 IU+ Tetanus Toxoid ≥ 40 IU Bordetella Pertussis antigens: Toxoid 25µg+ Filamentous haemagglutinin +25µg+ Inactivated type 1 Poliomyelitis virus+40DU*†+ Inactivated type 2 Poliomyelitis virus + 8DU*†+ Inactivated type 3 Poliomyelitis virus+ 32 DU*† *DU: antigen D unit † or eq. antigenic quantity determined by a suitable immunochemical method
|
Injectabe Vaccine |
102-4649-011 |
Sanofi Pasteur, France |
18.05.2016 |
Sanofi Bangladesh Limited., Dhaka |
36. |
Stamaril
|
Yellow fever Virus 17 D-204 Strain (Live attenuated) ≥ 1000 LD50 units |
Injectabe Vaccine |
102-4650-011 |
Sanofi Pasteur, France |
15.05.2021 |
Sanofi Bangladesh Limited., Dhaka |
37. |
Synflorix |
Pnenmococcal Polysaccharide Serotype 1 1.2 INN 1mcg+ Pnenmococcal Polysaccharide Serotype 4 1.2 INN 3mcg+ Pnenmococcal Polysaccharide Serotype 5 1.2 INN 1mcg + Pnenmococcal Polysaccharide Serotype 6B 1.2 INN 1mcg+ Pnenmococcal Polysaccharide Serotype 7F 1.2 INN 1mcg+ Pnenmococcal Polysaccharide Serotype 9V 1.2 INN 1mcg+ Pnenmococcal Polysaccharide Serotype 14 1.2 INN 1mcg+ Pnenmococcal Polysaccharide Serotype 18C 1.3 INN 3mcg + Pnenmococcal Polysaccharide Serotype 19F 1.4 INN 3mcg+ Pnenmococcal Polysaccharide Serotype 23F 1.2 INN 1mcg+ 1adsorbed on aluminium phosphate 0.5mg Al3+ 2Conjugated to protein D (derved from non-typeaable Haemophilus influenzae) Carrier protein 9-16mcg 3Conjugated to tetanus toxoid carrier protein 5-10mcg 4Conjugated to diphtheria toxoid carrier protein 3-6mcg/0.5ml |
Injectable Vaccine |
105-4663-011 |
GlaxoSmithkline Biological s.a. Belgium |
20.07.2021 |
GlaxoSmith Kline Bangladesh Ltd., Dhaka |
38. |
BCG-Medac |
Bacillus calmette-Guerin strain (seed RIVM derived from Seed 1173-p2) at least 2x108 and not more than 2x109 Viable units |
Injectable Vaccine |
221-4684-001 |
Medac Gesellschaft fur Klinische spezialpraparate Germany |
12.11.2021 |
Tajarat Healthcare marketing Ltd, Dhaka |
39. |
Prevenar 13 |
Pneumococcal Polysaccharide serotype 1 2.2µg + Pneumococcal Polysaccharide serotype 3 2.2µg + Pneumococcal Polysaccharide serotype 4 2.2µg + Pneumococcal Polysaccharide serotype 5 2.2µg + Pneumococcal Polysaccharide serotype 6A 2.2µg + Pneumococcal Polysaccharide serotype 6B 4.4µg + Pneumococcal Polysaccharide serotype 7F 2.2µg + Pneumococcal Polysaccharide serotype 9V 2.2µg + Pneumococcal Polysaccharide serotype 14 2.2µg + Pneumococcal Polysaccharide serotype 18C 2.2µg + Pneumococcal Polysaccharide serotype 19A 2.2µg + Pneumococcal Polysaccharide serotype 19F 2.2µg + Pneumococcal Polysaccharide serotype 23F 2.2µg |
Injectable Vaccine |
213-4690-011 |
Jhon Wyeth & Brother Ltd. UK and Marketing Authorisation Holder Wyeth Lederle Vaccine SA Belgium |
26.11.2021 |
Janata Traders, Dhaka |
40. |
Vaxigrip Enfants |
A/California/7/2009(H1N1)-derived Strain Used NYMC X-179A 7.5 Micrograms HA**+ A/Perth/16/2009 (H3N2)-Like strain used NYMC X-187 Derived from A/Victoria/210/2009 7.5 Micrograms HA**+ B/Brisbane/60/2008 7.5 Micrograms HA** Per 0.25ml dose |
Injectable Vaccine |
102-4732-012 |
Sanofi Pasteur SA, , France |
02.02.2017 |
Sanofi Bangladesh Limited., Dhaka |
41. |
Td-Pur |
purified tetanus Toxide Concentrate Nol Less than 20IU+ purified Diphtheria Toxide Concentrate Nol Less than 2IU/0.5ml |
Injectable Vaccine |
236-4744-012 |
Novartis Vaccine and Diagnostics Germany |
01.02.2017 |
GlaxoSmith Kline Bangladesh Ltd., Dhaka |
42. |
Menveo |
Meningococcal group A oligosacchardi conjugated to corynebacterium diphtheriae GRM 197Protein (Contained in the Powder 10.00mcg (16.7 to 33.3mcg) + Meningococcal group C oligosacchardi conjugated to corynebacterium diphtheriae GRM197 Protein (Contained in the Solution 5.00mcg (7.1 to 12.5mcg)+ Meningococcal group W-135 oligosacchardi conjugated to corynebacterium diphtheriae GRM197Protein (Contained in the Solution 5.00mcg (3.3 to8.3mcg)+ Meningococcal group Y oligosacchardi conjugated to corynebacterium diphtheriae GRM 197 Protein (Contained in the Solution 5.00mcg (5.6 to 10.0mcg) |
Injectable Vaccine |
236-4743-012 |
Novartis Vaccine and Diagnostics Germany |
21.02.2022 |
GlaxoSmith Kline Bangladesh Ltd., Dhaka |
43. |
MENUMONE-A/C/Y/W-135 |
Meningococcal Polysacharide of Neisseria Meningitis Gr. A 50µg + Meningococcal Polysacharide of Neisseria Meningitis Gr. B 50µg + Meningococcal Polysacharide of Neisseria Meningitis Gr. C 50µg + Meningococcal Polysacharide of Neisseria Meningitis Gr. W-135 50µg/1.5ml Vial |
Injection |
102-4779-13 |
Sanofi Pasteur Inc., USA |
04.02.2018 |
Sanofi Bangladesh Limited., Dhaka |
44. |
MENUMONE-A/C/Y/W-135 |
Meningococcal Polysacharide of Neisseria Meningitis Gr. A 50µg + Meningococcal Polysacharide of Neisseria Meningitis Gr. B 50µg + Meningococcal Polysacharide of Neisseria Meningitis Gr. C 50µg + Meningococcal Polysacharide of Neisseria Meningitis Gr. W-135 50µg/1.5ml Vial |
Injection |
102-4780-13 |
Sanofi Pasteur Inc., USA |
04.02.2018 |
Sanofi Bangladesh Limited., Dhaka |
45. |
Tetanol pur |
Purified Tetanus Toxoid |
Vaccine |
236-4702-011 |
GP Grenzach Produktions Gmbh, Germany |
10.12.2016 |
GlaxoSmith Kline Bangladesh Ltd., Dhaka |
46. |
GARDASIL (Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant vaccine) |
Type 6L1 protein INN 20 µgType 11L1 protein INN 40 µg Type 16L1 protein INN 40 µg Type 18L1 protein INN 20 µg |
Suspension for Injection |
213-4858-14 |
Merck Sharp & Dohme Corp., USA |
27.04.2024 |
Healthcare Pharmaceutical Ltd, Dhaka |
47. |
RotaTeq (Rotavirus Vaccine, Live, Oral, Pentavalent) |
G1 Reassortant INN ≥2.2 x 106 IU/DoseG2 Reassortant INN ≥2.8 x 106 IU/Dose G3 Reassortant INN ≥2.2 x 106 IU/Dose G4 Reassortant INN ≥2.0 x 106 IU/Dose P1 Reassortant INN ≥2.3 x 106 IU/Dose |
Suspension for oral Administration Single Dose |
213-4859-14 |
Merck Sharp & Dohme Corp., USA |
27.04.2024 |
Healthcare Pharmaceutical Ltd, Dhaka |
48. |
Pneumovax 23 (Pneumococcal Vaccine Polyvalent) |
Pneumococcal Polysaccharide INN 25mcg/dose of each type |
Single dose vial |
213-4860-14 |
Merck Sharp & Dohme Corp., USA |
27.04.2024 |
Healthcare Pharmaceutical Ltd, Dhaka |
49. |
VARIVAX |
Oka/Merck Varicella Virus INN 1350 PFU (Plaque-forming units) |
Powder and solvent for suspension for injection |
213-5197-016 |
Merck Sharp & Dohme Corp., USA |
27.04.2024 |
Healthcare Pharmaceutical Ltd, Dhaka |
50. |
Vaxigrip Tetra Quadvivalent Influenza vaccine |
-A/Michigan/45/2015 (H1N1) pdm 09-like Strain (A/Michigan/45/2015, NYMC x-275 -A/Hong Kong/4801/2014 (H3N2)-Like Strain (A/Hong Kong/4801/2014, NYMC x-263B) -B/Brishane/60/2008-Like strain (B/Brisbane/60/2008, wild type) -B/Phuket/3073/2013-Like strain (B/Phuket/3073/2013, wild type |
Vaccine |
97-5892-017 |
Sanofi Pasteur SA, France |
26.02.2022 |
Sanofi Bangladesh Ltd.
|
51. |
Nimenrix Powder and Solvent for Solution for Injection in pre-filled syringes. |
Neisseria meningitidis group A polysaccharide 5mcg + Neisseria meningitidis group C polysaccharide 5mcg+ Neisseria meningitidis group W-135 polysaccharide 5mcg+ Neisseria meningitidis group Y polysaccharide 5mcg+ Conjugated to tetanus toxoid carrier protein 44mcg |
Powder and Solvent for Injection |
366-6324-018 |
Made by GlaxoSmithKline Biologicals S.A., Belgium for Pfizer Limited, United Kingdom
Batch releasing site: Pfizer manufacturing Belgium NV, Rijksweg 12, B-2870 Puurs, Belgium |
11.04.2026 |
Radiant Export Import Enterprise, Dhaka |
52. |
Prevenar 13(Vaccine) |
Pneumococcal polysaccharide serotype (13-valent, adsorbed) |
Suspension for Injection |
366-6663-020 |
Pfizer Manufacturing Belgium NV, Rijksweg 12, 2870 Puurs, Belgium. |
24.02.2024 |
Radiant Export Import Enterprise, Dhaka |
53. |
Tetraxim |
Diphtheria toxoid ≥ 30 IUTetanus Toxoid ≥ 40 IUBordetella pertussis antigens: Toxoid 25μgFilamentous haemagglutinin 25μgInactivated type 1 Poliomyelitis virus 40DUInactivated type 2 Poliomyelitis virus 8DU Inactivated type 3 Poliomyelitis virus 32 DU / 1 dose (0.5 ml) |
Suspension for Injection in prefilled syringe |
102-6688-020 |
Manufactured by:Sanofi Pasteur, Parc Industriel d’Incarville 27100 Val de Reuil France,Marketing Authorization Holder (MAH):Sanofi Pasteur, 14 Espace Henry Vallee, 69007 Lyon, France |
12.10.2025 |
Sanofi Bangladesh Limited., |
54. |
Prevenar 13
|
Pneumococcal Polysaccharide serotype Ph. Eur. 1,3,4,5,6A, 6B, 7F,9V,14,18C,19A,19F,23F |
Suspension for Injection |
213-6697-2020 |
Pfizer Ireland Pharmaceuticals, Grange Castle, Business Park Clondalkin, Dublin-22, Ireland (also responsible for quality control and primary packaging) & site responsible for Secondary Packaging & Batch release by Pfizer Manufacturing Belgium NV, Rijksweg 12, 2870 Puurs, Belgium |
09.12.2025 |
M/s. Janata Traders, 62/2, Purana Paltan, Dhaka
Date: 10.12.2020 |
55. |
Nimenrix
|
Neisseria meningitidis group A polysaccharide In-House 5mcg + Neisseria meningitidis group C polysaccharide In-House 5mcg+ Neisseria meningitidis group W-135 polysaccharide In-House 5mcg+ Neisseria meningitidis group Y polysaccharide In-House 5mcg+ Conjugated to tetanus toxoid carrier protein 44mcg) |
Powder and Solvent for Solution for Injection in pre-filled syringes |
366-6718-2021 |
Pfizer Manufacturing Belgium NV, Rijksweg 12, B-2870 Puurs, Belgium (also responsible for batch release in the EU, quality control, primary and secondary packaging) |
03.04.2026 |
M/s Radiant Export Import Enterprise,
Date: 04.04.2021 |